|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Amortization of discount on convertible note | |||||
| Amortization of premium on convertible note | |||||
| Stock-based compensation expense | |||||
| Provision for expected credit losses | |||||
| Restructuring charges | |||||
| Impairment of right-of-use assets | |||||
| Real estate and internal-use software | |||||
| Gain on lease modification | |||||
| Gain on convertible note extinguishment | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred commissions | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Cash paid for website domain name | |||||
| Cash paid for acquisition | |||||
| Purchase of property, equipment, leasehold improvements and capitalized internal-use software | |||||
| Proceeds from marketable securities | |||||
| Purchase of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net share settlement of stock options | |||||
| Holdback payments related to business combination | |||||
| Proceeds from financing obligation | |||||
| Payment of convertible note issuance costs | |||||
| Purchase of capped calls | |||||
| Repayment of convertible notes and financing obligation | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Noncash investing and financing activities: | |||||
| Changes in capital additions, accrued but not paid | |||||
| Fair value of shares issued as consideration for business combinations | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Right-of-use asset obtained in exchange for new operating lease liability | |||||
| Principal amount of 2028 Convertible Notes exchanged | |||||
Loading...